• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Innovent Ph 2 Of Picankibart In Ulcerative Colitis Met Endpoint

    PR NEWSWIRE

    Enforcement Report - Week of March 29, 2023

    FDA

    XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD

    PR NEWSWIRE

    Enforcement Report - Week of December 7, 2022

    FDA

    Noven To Participate In Annual International Conference On Adhd (Chadd)

    PRNEWSWIRE

    Noven To Present Poster Data At The AACAP & CACAP Conference

    PRNEWSWIRE

    Enforcement Report - Week of July 6, 2022

    FDA

    Enforcement Report - Week of August 25, 2021

    FDA

    Noven to Present Pivotal Study Results for Investigational Dextroamphetamine

    BUSINESSWIRE

    Enforcement Report - Week of March 10, 2021

    FDA

    Noven Submits New Drug Application for Investigational Dextroamphetamine

    BUSINESSWIRE

    Noven Submits New Drug Application for Investigational Dextroamphetamine

    BUSINESSWIRE

    Enforcement Report - Week of April 29, 2020

    FDA

    SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch

    BUSINESSWIRE

    Enforcement Report - Week of March 25, 2020

    FDA

    FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia

    BIOSPACE

    Categorical Response &Clinical Relevance as Assessed in a PhIII Study of HP-3070

    BUSINESSWIRE

    Enforcement Report - Week of October 3, 2018

    FDA

    Enforcement Report - Week of May 16, 2018

    FDA

    Farxiga® (Estradiol ): Noven Pharmaceuticals, v. Amneal Pharmaceuticals

    PATENT LITIGATION

    Enforcement Report - Week of April 25, 2018

    FDA

    Enforcement Report - Week of September 27, 2017

    FDA

    Enforcement Report - Week of July 5, 2017

    FDA

    Patent:Novartis AG v. Noven Pharmaceuticals Inc.

    PATENT DOC

    FDA issues Noven another warning letter for factory that produces ADHD patches

    FIERCE PHARMA

    Noven Pharmaceuticals, Inc. Receives FDA Warning Letter

    FDA

    Noven ADHD patches in short supply after recall

    FIERCE PHARMA

    Data integrity concerns make Health Canada issue alert at Noven Pharmaceuticals, Inc.

    Noven Pharmaceuticals, Inc. initiates Class II recall of Methylphenidate transdermal system

    FDA

    Noven Pharma, Hisamitsu Pharma sue Mylan on generic Minivelle

    PHARMA BIZ

    Noven Pharmaceuticals, Inc., Ongoing Class II recall of Minivelle (estradiol transdermal system) 0.05 mg/day, 8-count box, Rx only, Manufactured by Noven Pharmaceuticals, Inc., Miami, Florida 33186, Distributed by Noven Pharmaceuticals, LLC, Miami, Florida 33186, NDC 68968-6650-8 because of Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

    FDA

    Up and Down the Ladder: The Latest Comings & Goings at Orexigen, Pfizer and…

    PHARMALOT

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.